Effect of dopamine and calcium on lipolysis and myocardial ischemic injury following acute coronary occlusion in the dog.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D004562:Electrocardiography; D000431:Ethanol / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000503:physiopathology; D011725:Pyridines / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; D011725:Pyridines; D014665:Vasodilator Agents; D000431:Ethanol; D005934:Glucagon; D002118:Calcium; D004298:Dopamine